Alzheimer's Drug Discovery Foundation
Melvin R. Goodes joined Warner-Lambert Canada as manager of new product development in 1965 and quickly rose through the ranks to become CEO and Chairman Worldwide in 1991. He helped the pharmaceutical company become a major player in the prescription drug industry by bringing Lipitor to market in 1996. Lipitor had sales of $2.2 billion in 1998 and is one of the largest selling drugs in history.
Mr. Goodes earned his bachelors of commerce degree and was granted an honorary Doctorate of Laws from Queen's University in Kingston, Ontario. He received an MBA from the University of Chicago Booth School of Business, where he was a Ford Foundation and Sears Roebuck fellow. In 2010, Mr. Goodes made headlines with a landmark speech revealing his early-stage Alzheimer's disease and pledging his all to speed the search for new therapies.
This person is not in the org chart
This person is not in any offices
Alzheimer's Drug Discovery Foundation
Founded in 1998 by Leonard A. Lauder and Ronald S. Lauder, the Alzheimer’s Drug Discovery Foundation (ADDF) was one of the first charities to adopt the venture philanthropy model. Our mission is to rapidly accelerate the discovery of drugs to prevent and treat Alzheimer’s disease and related dementias. We are the only charity focused solely on supporting new drugs for Alzheimer’s.